Johnson & Johnson (JNJ) Gains from Investment Securities (2009 - 2026)

Johnson & Johnson's Gains from Investment Securities history runs 18 years deep, the most recent figure standing at $54.0 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 80.0% year-over-year to $54.0 million; the TTM figure through Mar 2026 stood at $186.0 million (down 6.53% YoY), while the FY2025 annual figure was $162.0 million, down 6.9% from the prior year.
• Gains from Investment Securities came in at $54.0 million for Q1 2026 at Johnson & Johnson, down from $63.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $111.0 million in Q4 2023 to a low of -$185.0 million in Q1 2023.
• A 5-year average of $16.8 million and a median of $33.0 million in 2025 frame the typical range for Gains from Investment Securities.
• Across the five-year window, Gains from Investment Securities plunged 85.59% in 2024 and jumped 500.0% in 2025, its largest moves.
• Johnson & Johnson's Gains from Investment Securities stood at $59.0 million in 2022, then sank by 276.27% to -$104.0 million in 2023, then soared by 169.23% to $72.0 million in 2024, then fell by 12.5% to $63.0 million in 2025, then retreated by 14.29% to $54.0 million in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $54.0 million, $63.0 million, and $33.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison